Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system
Applied and Environmental Microbiology · 23.10.2024 · 90 (10)
DOI: 10.1128/aem.00811-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied and Environmental Microbiology, erschienen am 23.10.2024. Verfasst von Mengdie Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Escherichia coli, Probiotics, CRISPR-Cas Systems, Anti-Bacterial Agents. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Key Research and Development Program of Zhejiang Province (Key R&D plan of Zhejiang Province), Open Foundation of State Key Laboratary Cultivation Base of Hazard Factors and Risk Control of Quanlity and Safety of Agticultural Products.
Abstract (Originalsprache)
Many multidrug-resistant (MDR) bacteria have evolved through the accumulation of antibiotic resistance genes (ARGs). Although the potential risk of probiotics as reservoirs of ARGs has been recognized, strategies for blocking the transfer of ARGs while using probiotics have rarely been explored. The probiotic Escherichia coli Nissle 1917 (EcN) has long been used for treating intestinal diseases. Here, we demonstrate frequent transfer of ARGs into EcN both in vitro and in vivo , raising concerns about its potential risk of accumulating antibiotic resistance. Given that no CRISPR-Cas system was found in natural EcN, we integrated the type I-E CRISPR-Cas3 system derived from E. coli BW25113 into EcN. The engineered EcN was able to efficiently cleave multiple ARGs [i.e., mcr-1 , bla NDM-1 , and tet (X)] encoding enzymes for degrading last-resort antibiotics. Through co-incubation of EcN expressing Cas3-Cascade and that expressing Cas9, we showed that the growth of the former strain outcompeted the latter strain, demonstrating a better clinical application prospect of EcN expressing the type I-E CRISPR-Cas3 system. In the intestine of a model animal (i.e., zebrafish), the engineered EcN exhibited immunity against the transfer of CRISPR-targeted ARGs. Our work equips EcN with immunity against the transfer of multiple ARGs by exploiting the exogenous type I-E CRISPR-Cas3 system, thereby reducing the risk of the spread of ARGs while using it as a probiotic chassis for generating living therapeutics. IMPORTANCE To reduce the development of antibiotic resistance, probiotics have been considered as a substitute for antibiotics. However, probiotics themselves are reservoirs of antibiotic resistance genes (ARGs). This study introduces a new strategy for limiting the spread of ARGs by engineering the typical probiotic strain Escherichia coli Nissle 1917 (EcN), which has been used for treating intestinal diseases and developed as living therapeutics. We also demonstrate that the type I CRISPR-Cas system imposes a lower growth burden than the type II CRISPR-Cas system, highlighting its promising clinical application potential. Our work not only provides a new strategy for restricting the transfer of ARGs while using probiotics but also enriches the genetic engineering toolbox of EcN, paving the way for the safe use and development of probiotics as living therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, Zhejiang, China.
- School of Laboratory Medicine and Bioengineering, Hangzhou Medical College, Hangzhou, Zhejiang, China.
- State Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-Products, Institute of Agro-product Safety and Nutrition, Zhejiang Academy of Agricultural Sciences, Hangzhou, Zhejiang, Ch…
- Key Laboratory of Systems Health Science of Zhejiang Province, School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang, China.
ORCID-Profile: Mengdie Fang, Biao Tang, Dongchang Sun
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- Key Research and Development Program of Zhejiang Province (Key R&D plan of Zhejiang Province)
- Open Foundation of State Key Laboratary Cultivation Base of Hazard Factors and Risk Control of Quanlity and Safety of Agticultural Products
- MOST | NSFC | NSFC-Zhejiang Joint Fund | | Basic Public Welfare Research Program of Zhejiang Province ()
- Foundation of Zhejiang Academy of Medical Sciences
- MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Basic Public Welfare Research Program of Zhejiang Province
Zitieren
APA
Fang, M., Zhang, R., Wang, C., Liu, Z., Fei, M., Tang, B., Yang, H., & Sun, D. (2024). Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system. Applied and Environmental Microbiology, 90(10). https://doi.org/10.1128/aem.00811-24
Vancouver
Fang M, Zhang R, Wang C, Liu Z, Fei M, Tang B, et al. Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system. Applied and Environmental Microbiology. 2024;90(10). doi:10.1128/aem.00811-24
BibTeX
@article{Fang2024,
author = {Fang, Mengdie and Zhang, Ruiting and Wang, Chenyu and Liu, Zhizhi and Fei, Mingyue and Tang, Biao and Yang, Hua and Sun, Dongchang},
title = {Engineering probiotic Escherichia coli Nissle 1917 to block transfer of multiple antibiotic resistance genes by exploiting a type I CRISPR-Cas system},
journal = {Applied and Environmental Microbiology},
year = {2024},
volume = {90},
number = {10},
doi = {10.1128/aem.00811-24}
}
EUVIMED